203 related articles for article (PubMed ID: 21605730)
21. Low-dose vitamin K to augment anticoagulation control.
Reese AM; Farnett LE; Lyons RM; Patel B; Morgan L; Bussey HI
Pharmacotherapy; 2005 Dec; 25(12):1746-51. PubMed ID: 16305294
[TBL] [Abstract][Full Text] [Related]
22. Initiation of warfarin therapy in elderly medical inpatients: a safe and accurate regimen.
Siguret V; Gouin I; Debray M; Perret-Guillaume C; Boddaert J; Mahé I; Donval V; Seux ML; Romain-Pilotaz M; Gisselbrecht M; Verny M; Pautas E
Am J Med; 2005 Feb; 118(2):137-42. PubMed ID: 15694897
[TBL] [Abstract][Full Text] [Related]
23. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy.
Sarode R; Rawal A; Lee R; Shen YM; Frenkel EP
Br J Haematol; 2006 Mar; 132(5):604-7. PubMed ID: 16445834
[TBL] [Abstract][Full Text] [Related]
24. Dietary vitamin K intake and anticoagulation in elderly patients.
Rohde LE; de Assis MC; Rabelo ER
Curr Opin Clin Nutr Metab Care; 2007 Jan; 10(1):1-5. PubMed ID: 17143047
[TBL] [Abstract][Full Text] [Related]
25. PPSB as first choice treatment in the reversal of oral anticoagulant therapy.
Strengers PF; Drenth JC
Acta Anaesthesiol Belg; 2002; 53(3):183-6. PubMed ID: 12461827
[TBL] [Abstract][Full Text] [Related]
26. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Ansell J; Hirsh J; Hylek E; Jacobson A; Crowther M; Palareti G
Chest; 2008 Jun; 133(6 Suppl):160S-198S. PubMed ID: 18574265
[TBL] [Abstract][Full Text] [Related]
27. Vitamin K to correct overanticoagulation.
Jindeel A
Ann Intern Med; 2009 Sep; 151(6):434; author reply 435. PubMed ID: 19755379
[No Abstract] [Full Text] [Related]
28. Vitamin K to correct overanticoagulation.
Kumar PD
Ann Intern Med; 2009 Sep; 151(6):434-5; author reply 435. PubMed ID: 19755378
[No Abstract] [Full Text] [Related]
29. Vitamin K to correct overanticoagulation.
Pengo V; Denas G; Jose SP
Ann Intern Med; 2009 Sep; 151(6):433; author reply 435. PubMed ID: 19755377
[No Abstract] [Full Text] [Related]
30. Vitamin K to correct overanticoagulation.
Pendleton RC; Vazquez S
Ann Intern Med; 2009 Sep; 151(6):433-4; author reply 435. PubMed ID: 19755376
[No Abstract] [Full Text] [Related]
31. Vitamin K to correct overanticoagulation.
Swaim MW; Macik BG
Ann Intern Med; 2009 Sep; 151(6):432-3; author reply 435. PubMed ID: 19755375
[No Abstract] [Full Text] [Related]
32. Probable interaction between an oral vitamin K antagonist and turmeric (Curcuma longa).
Daveluy A; Géniaux H; Thibaud L; Mallaret M; Miremont-Salamé G; Haramburu F
Therapie; 2014; 69(6):519-20. PubMed ID: 25230280
[TBL] [Abstract][Full Text] [Related]
33. The risk of hemorrhage among patients with warfarin-associated coagulopathy.
Garcia DA; Regan S; Crowther M; Hylek EM
J Am Coll Cardiol; 2006 Feb; 47(4):804-8. PubMed ID: 16487849
[TBL] [Abstract][Full Text] [Related]
34. The use of vitamin K in patients on anticoagulant therapy: a practical guide.
Hanslik T; Prinseau J
Am J Cardiovasc Drugs; 2004; 4(1):43-55. PubMed ID: 14967065
[TBL] [Abstract][Full Text] [Related]
35. Retrospective evaluation of a method to predict fresh-frozen plasma dosage in anticoagulated patients.
Frazee LA; Bourguet CC; Gutierrez W; Elder-Arrington J; Elackattu AE; Haller NA
Am J Ther; 2008; 15(2):111-8. PubMed ID: 18356630
[TBL] [Abstract][Full Text] [Related]
36. Bleeding risks and response to therapy in patients with INR higher than 9.
Pagano MB; Chandler WL
Am J Clin Pathol; 2012 Oct; 138(4):546-50. PubMed ID: 23010709
[TBL] [Abstract][Full Text] [Related]
37. Anticoagulation management in hip fracture patients on warfarin.
Al-Rashid M; Parker MJ
Injury; 2005 Nov; 36(11):1311-5. PubMed ID: 16214475
[TBL] [Abstract][Full Text] [Related]
38. Impact of pre-treatment INR level on the effect of intravenous low dose vitamin K in patients with excessive anticoagulation.
Lubetsky A; Shasha Y; Olchovsky D; Loebstein R; Halkin H; Ezra D
Thromb Haemost; 2003 Jul; 90(1):71-6. PubMed ID: 12876628
[TBL] [Abstract][Full Text] [Related]
39. Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin.
Crowther MA; Ageno W; Schnurr T; Manfredi E; Kinnon K; Garcia D; Douketis JD
Haematologica; 2005 Jan; 90(1):137-9. PubMed ID: 15642685
[TBL] [Abstract][Full Text] [Related]
40. Risk factors of vitamin K antagonist overcoagulation.
Marie I; Leprince P; Menard JF; Tharasse C; Levesque H
QJM; 2012 Jan; 105(1):53-62. PubMed ID: 21880698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
